A prospective randomised study from Eastern India comparing Basiliximab versus no induction immunosuppression in low immunological risk kidney transplant recipients

被引：0
|
作者：
Gosain, Varun [1 ]
Rout, Shashibhushan [2 ]
机构：
[1] Fortis Mem Res Inst, Nephrol & Kidney Transplant, Gurgaon, India
[2] SCB Govt Med Coll, Nephrol & Kidney Transplant, Cuttack, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.533
引用
收藏
页码：718 / 718
页数：1
相关论文
共 50 条
  • [1] Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
    Ajlan, Aziza
    Aleid, Hassan
    Ali, Tariq Zulfiquar
    Joharji, Hala
    Almeshari, Khalid
    Nazmi, Ahmed Mohammed
    Shah, Yaser
    Devol, Edward
    Alkortas, Dalal
    Alabdulkarim, Zinah
    Broering, Dieter
    Alahmadi, Ibrahim
    Ullah, Asad
    Alotaibi, Anwar
    Aljedai, Ahmed
    TRIALS, 2021, 22 (01)
  • [2] Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
    Aziza Ajlan
    Hassan Aleid
    Tariq Zulfiquar Ali
    Hala Joharji
    Khalid Almeshari
    Ahmed Mohammed Nazmi
    Yaser Shah
    Edward Devol
    Dalal Alkortas
    Zinah Alabdulkarim
    Dieter Broering
    Ibrahim Alahmadi
    Asad Ullah
    Anwar Alotaibi
    Ahmed Aljedai
    Trials, 22
  • [3] Standard Induction with Basiliximab versus no Induction in Low Immunological Risk Kidney Transplant Recipients: Study Protocol for a Randomized Controlled Trial.
    Ajlan, A.
    Aleid, H.
    Ali, T.
    Joharji, H.
    Alabdulkarim, Z.
    Aburiash, T.
    Almeshari, K.
    Nazmi, A.
    Shah, Y.
    Devol, E.
    Alkortas, D.
    Broering, D.
    Alahmadi, I.
    Ullah, A.
    Alotaibi, A.
    Aljedai, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 945 - 946
  • [4] Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis
    Zhang, Dahao
    Wen, Jiqiu
    Dong, Jianhui
    Ma, Rong
    Li, Shijian
    Wu, Jihua
    Wen, Ning
    Lei, Zhiying
    Li, Haibin
    Yin, Jun
    Sun, Xuyong
    RENAL FAILURE, 2025, 47 (01)
  • [5] Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression
    Lacave, Florian
    de Terwangne, Christophe
    Darius, Tom
    Buemi, Antoine
    Mourad, Michel
    France, Yannick
    Coelho, Joana Cardoso
    Fernandes, Guillaume
    Goffin, Eric
    Devresse, Arnaud
    Kanaan, Nada
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [6] Use of Basiliximab Induction in Low-Immunological Risk Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression
    Gavela Martinez, E.
    Avila Bernabeu, A. I.
    Sancho Calabuig, A.
    Beltran Catalan, S.
    Escudero Quesada, V.
    Pallardo Mateu, L. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2337 - 2338
  • [7] INDUCTION THERAPY IN ELDERLY KIDNEY TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGICAL RISK
    Masset, C.
    Boucquemont, J.
    Garandeau, C.
    Buron, F.
    Morelon, E.
    Girerd, S.
    Ladriere, M.
    Mourad, G.
    Garrigue, V.
    Cassuto, E.
    Albano, L.
    Foucher, Y.
    Dantal, J.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 11 - 11
  • [8] Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk
    Masset, Christophe
    Boucquemont, Julie
    Garandeau, Claire
    Buron, Fanny
    Morelon, Emmanuel
    Girerd, Sophie
    Ladriere, Marc
    Mourad, Georges
    Garrigue, Valerie
    Cassuto, Elisabeth
    Albano, Laetitia
    Foucher, Yohann
    Dental, Jacques
    TRANSPLANTATION, 2020, 104 (03) : 613 - 622
  • [9] Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients in the Current Era of Immunosuppression
    Zachariah, M.
    Mallawaarachchi, I.
    Meeks, N.
    Wright, D.
    Minawala, R.
    Liu, V.
    Rolls, J.
    Hussein, S.
    Jarrin, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 914 - 914
  • [10] Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience
    Lee, H.
    Lee, S.
    Jeon, J. S.
    Kwon, S. H.
    Noh, H.
    Han, D. C.
    Yun, S.
    Song, D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1285 - 1288
12345